LFE life therapeutics limited

life therapeutics to supply anti anthrax plasma

  1. fluffynymph
    56,659 Posts.
    lightbulb Created with Sketch. 267
    clock Created with Sketch.
    06/09/06
    12:09
    Post #: 1778095
    Sydney - Wednesday - September 6: (RWE Aust Business News) - Life
    Therapeutics (ASX:LFE) will supply Cangene Corp with anti-anthrax plasma
    to produce a hyperimmune product for the US Department of Health and
    Human Services.
    This is a $US143m project for Cangene under Project BioShield to
    produce 10,000 doses of anthrax immune globulin for treating inhalational
    anthrax.
    LFE Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ASX:MIN - $1.1 billion gas deal reached with Hancock
right-arrow Created with Sketch.
NEWS ASX:TLG - Supreme Court dismisses mine environmental appeals
right-arrow Created with Sketch.
NEWS MinRes chief Ellison's tax concerns have hurt shares – but are markets overreacting?
right-arrow Created with Sketch.
NEWS Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too
right-arrow Created with Sketch.
watchlist Created with Sketch. Add LFE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.